MARKET

CERS

CERS

Cerus
NASDAQ
2.635
+0.045
+1.74%
Opening 12:52 06/24 EDT
OPEN
2.590
PREV CLOSE
2.590
HIGH
2.650
LOW
2.565
VOLUME
1.08M
TURNOVER
--
52 WEEK HIGH
3.150
52 WEEK LOW
1.150
MARKET CAP
527.97M
P/E (TTM)
-53.0181
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CERS last week (0615-0619)?
Weekly Report · 2d ago
Cerus showcases INTERCEPT Blood System evidence at ISBT Congress
PUBT · 06/17 12:30
Weekly Report: what happened at CERS last week (0608-0612)?
Weekly Report · 06/15 09:39
Cerus director Eric Bjerkholt disposes of 20,454 common shares worth $53,180.40
PUBT · 06/12 01:17
Cathie Wood Sells Robinhood Stock, Doubles Down On This George Soros-Backed AI Stock
Benzinga · 06/11 02:43
Cerus amends credit facilities, expands term loan capacity
TipRanks · 06/08 21:40
Cerus closes debt facility up to $110M
TipRanks · 06/08 12:45
CERUS - ENTERS NEW 5-YEAR REVOLVING LOAN AGREEMENT UP TO $45 MLN
Reuters · 06/08 12:31
More
About CERS
Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.

Webull offers Cerus Corp stock information, including NASDAQ: CERS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERS stock methods without spending real money on the virtual paper trading platform.